Turn Biotechnologies to Present at the JMP Securities Life Sciences Conference

MOUNTAIN VIEW, Calif., May 9, 2023 /PRNewswire/ — Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines for untreatable, age-related conditions, today announced that Chief Executive Officer, Anja Krammer, will present an updated corporate overview at the JMP…